524 related articles for article (PubMed ID: 24446755)
1. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo.
Zhang DM; Hong WS; Fu LF; Wei XD; Xu AE
Dermatol Surg; 2014 Apr; 40(4):420-6. PubMed ID: 24446755
[TBL] [Abstract][Full Text] [Related]
2. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients.
Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP
J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467
[TBL] [Abstract][Full Text] [Related]
5. Successful Treatment of Stable Vitiligo by Low-Density Cultured Autologous Melanocyte Transplantation Combined With Narrowband Ultraviolet B Therapy.
Yao L; Liu Y; Song Y; Zhong S; Li S
Dermatol Surg; 2017 Oct; 43(10):1281-1287. PubMed ID: 28445194
[TBL] [Abstract][Full Text] [Related]
6. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
[TBL] [Abstract][Full Text] [Related]
7. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
[TBL] [Abstract][Full Text] [Related]
8. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up and correlated factors of vitiligo following autologous epidermal transplantation.
Jin Y; Xu A; Wang P; Song X; Liu X
Cutis; 2011 Mar; 87(3):137-41. PubMed ID: 21488571
[TBL] [Abstract][Full Text] [Related]
10. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.
Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV
Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588
[TBL] [Abstract][Full Text] [Related]
11. Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial.
Verhaeghe E; Lodewick E; van Geel N; Lambert J
Dermatology; 2011; 223(4):343-8. PubMed ID: 22269666
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
Shin J; Lee JS; Hann SK; Oh SH
Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
[TBL] [Abstract][Full Text] [Related]
13. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
[TBL] [Abstract][Full Text] [Related]
14. Vitiligo, NB-UVB and tacrolimus: our experience in Naples.
Baldo A; Lodi G; Di Caterino P; Monfrecola G
G Ital Dermatol Venereol; 2014 Feb; 149(1):123-30. PubMed ID: 24566573
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy observation of fire needle combined with narrow band ultraviolet-B (NB-UVB) for vitiligo].
Zhang Y; Chen CT; Huang S; Zhou JW
Zhongguo Zhen Jiu; 2013 Feb; 33(2):121-4. PubMed ID: 23620938
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
[TBL] [Abstract][Full Text] [Related]
17. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
Li R; Qiao M; Wang X; Zhao X; Sun Q
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
[TBL] [Abstract][Full Text] [Related]
18. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
19. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
Abdelghani R; Ahmed NA; Darwish HM
J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
